Latest Alzheimer's antibody is 'not a miracle drug'.
Where this comes from
- Record sourced from PubMed, PMID 37167375.
- Also identified by DOI 10.1126/science.adi6515.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Results on Eli Lilly's donanemab highlight stark risk-benefit trade-offs.
Medical subject headings
- Alzheimer Disease
- Antibodies, Monoclonal